Literature DB >> 10882690

The effects of exposure at constant (1 h) or exponentially decreasing concentrations of quinupristin/dalfopristin on biofilms of Gram-positive bacteria.

S Gander1, R Finch.   

Abstract

Using a biofilm model, infections by Staphylococcus aureus, coagulase-negative staphylococci and enterococci were studied. The biofilms were exposed to quinupristin/dalfopristin and five comparator antibiotics: ciprofloxacin, vancomycin, teicoplanin, flucloxacillin and erythromycin. Two methods of exposure to the drugs were used: constant for 1 h, and exponentially decreasing, with the rate of dilution being matched to the half-lives of the antibiotics. The effects of antibiotic exposure were monitored by performing viable counts on the cells eluted from the biofilms. The results are presented as the inhibitory or bactericidal effect (the reduction in numbers of bacteria eluted from the biofilms) and recovery times (the time taken for the number of cells eluted from the biofilms to return to the number eluted before the drug exposure). Quinupristin/dalfopristin was the most effective of the six antibiotics studied, especially against enterococci. However, there were no significant differences in the effects, inhibitory/ bactericidal or recovery times, produced by the two methods of exposure. The two glycopeptides showed a surprising lack of activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10882690     DOI: 10.1093/jac/46.1.61

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  4 in total

1.  Combination of quinupristin-dalfopristin (Synercid) and rifampin is highly synergistic in experimental Staphylococcus aureus joint prosthesis infection.

Authors:  Azzam Saleh-Mghir; Nourdine Ameur; Claudette Muller-Serieys; Farid Ismael; Françoise Lemaitre; Laurent Massias; Céline Feger; Rémy Bléton; Anne-Claude Crémieux
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

2.  Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces.

Authors:  Julie A Wu; Caroline Kusuma; James J Mond; John F Kokai-Kun
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

3.  In vitro activity of vancomycin, quinupristin/dalfopristin, and linezolid against intact and disrupted biofilms of staphylococci.

Authors:  Mohamed El-Azizi; Suma Rao; Termkiat Kanchanapoom; Nancy Khardori
Journal:  Ann Clin Microbiol Antimicrob       Date:  2005-01-07       Impact factor: 3.944

4.  Antifungal activity of amphotericin B and voriconazole against the biofilms and biofilm-dispersed cells of Candida albicans employing a newly developed in vitro pharmacokinetic model.

Authors:  Mohamed El-Azizi; Noha Farag; Nancy Khardori
Journal:  Ann Clin Microbiol Antimicrob       Date:  2015-04-03       Impact factor: 3.944

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.